Core Viewpoint - The announcement by the Interbank Market Dealers Association regarding the evaluation results for member applications to engage in underwriting related to non-financial corporate debt financing tools for 2025 highlights the expansion of qualified institutions in this sector [1][4]. Group 1: Qualified Institutions - Several institutions, including Huatai United Securities, JPMorgan Chase Bank (China), DBS Bank (China), Shanxi Securities, and Caitong Securities, have obtained relevant business qualifications [2][4]. - A total of 37 members submitted applications for underwriting qualifications, with 8 new members recognized as general lead underwriters for non-financial corporate debt financing tools [4][5]. - Bank of China International Securities Co., Ltd. has been designated as a lead underwriter for technology innovation non-financial corporate debt financing tools [4]. Group 2: Underwriting Business Regulations - The announcement outlines that lead underwriters and underwriters must establish dedicated departments for underwriting business, appoint specialized personnel, and develop operational procedures, risk management, and internal control systems [7]. - Lead underwriters must collaborate with independently qualified lead underwriters to conduct underwriting business, and may independently engage in underwriting after gaining sufficient experience [7]. - The Association will suspend or revoke underwriting qualifications for lead underwriters or underwriters found guilty of significant legal or regulatory violations [7]. Group 3: Membership Classification - The Association categorizes underwriters into lead underwriter members, underwriting members, and intending underwriting members, with lead underwriter members further divided into general and specialized categories [8][9]. - General lead underwriter members can engage in all categories of non-financial corporate debt financing tool underwriting, while specialized members can only handle specific categories [8]. - Intending underwriting members are those interested in participating in underwriting but are not yet classified as underwriters [9].

Core Viewpoint - The approval of 18 new brokerage firms for non-financial corporate debt financing tool underwriting qualifications enhances the competitive landscape in the fixed income market in China [1] Group 1: New Brokerage Firms Approved - The China Interbank Market Dealers Association has released the list of 2025 non-financial corporate debt financing tool underwriting qualifications, adding 18 new brokerages this year [1] - Among the new additions, six brokerages, including Caitong Securities and First Capital Securities, are designated as general lead underwriters for non-financial corporate debt financing tools [1] - Zhongyin Securities has been approved as the lead underwriter for technology innovation non-financial corporate debt financing tools, which includes the underwriting of bonds supporting technological innovation [1] Group 2: Implications for Brokerage Firms - The approval of these qualifications is expected to assist brokerages in enhancing their fixed income business layout and improving their comprehensive bond business system [1]

Group 1: Core Insights - The report from Southwest Securities indicates that by early 2025, Hong Kong-listed companies will begin to achieve business development (BD) milestones, with innovative drugs leading the market surge [1] - The Chinese innovative drug sector is expected to accelerate following the government's support for drug pricing mechanisms and the development of innovative drugs and medical devices, as highlighted in the March government work report [1] - The innovative drug sector is predicted to transition from a broad market rally to a selective stock picking phase by 2026, with a focus on three key areas: overseas expansion, brain-computer interfaces, and AI in healthcare [1] Group 2: Overseas Expansion - By December 5, 2025, the number of BD projects for Chinese innovative drugs going overseas reached 166, an increase of 54 projects compared to the entire year of 2024 [1] - The upfront payments for these projects totaled $6.3 billion, representing a growth of over 199% from 2024 [1] - The total amount for overseas projects reached $141.97 billion, an increase of over 136.8% from 2024, with over 52% of the molecules in early clinical stages [1] Group 3: Brain-Computer Interfaces - The 15th Five-Year Plan emphasizes the development of brain-computer interfaces as a new economic growth point, with several provinces introducing fee standards and including some projects in medical insurance [2] - The application of brain-computer interface technology is primarily focused on medical rehabilitation, particularly for patients with stroke and spinal cord injuries, with potential expansion into education, entertainment, and industrial sectors [2] Group 4: AI in Healthcare - Five national departments issued guidelines to promote and regulate the application of AI in healthcare, setting clear short-term (by 2027) and long-term (by 2030) goals across eight major areas [3] - AI in healthcare is entering a new phase of technological integration and industry restructuring, with key applications including AI health management, clinical decision support systems, medical imaging diagnostics, surgical robotics, genetic sequencing, and drug development [3] Group 5: Recommended Companies - The report recommends several companies for investment, including Heng Rui Medicine, BeiGene, Mindray Medical, United Imaging Healthcare, and others, indicating a diverse portfolio in the healthcare sector [4]

Macro and Strategy - The fixed income investment strategy focuses on long-term bond wave operations, with a significant decline in default amounts in December, indicating a potential recovery in credit markets [7][8] - Domestic economic growth is expected to slow down, with GDP growth forecasted at approximately 4.3% for Q4 2025, remaining within the government's target range of around 5% [7][8] - The monetary policy meeting in Q4 removed references to "low price operation," indicating a shift in focus towards addressing supply-demand imbalances in the economy [8] Industry and Company - In the transportation sector, improvements in oil exchange rates are beneficial for the airline sector, while leading express companies are strengthening their competitive advantages [3][20] - The banking sector is expected to perform well leading up to the Spring Festival, with historical data showing a high success rate for bank stocks during this period [24][25] - The mechanical industry is seeing significant developments, with the establishment of a standardization committee for humanoid robots and ByteDance planning to invest $23 billion in AI [26][27] - The social services sector has seen a notable increase in duty-free sales in Hainan, with a 54.9% year-on-year growth, indicating strong consumer demand [33][34] - The express delivery industry is benefiting from price increases due to anti-involution policies, with major players like ZTO and YTO showing improved growth rates [22][23]

Core Viewpoint - The China Interbank Market Dealers Association announced the results of market evaluations for members applying to engage in underwriting non-financial corporate debt financing tools, adding 8 general lead underwriters, 1 technology innovation lead underwriter, and 15 underwriters [1]. Group 1: New General Lead Underwriters - Eight new members have been added as general lead underwriters for non-financial corporate debt financing tools, including Caitong Securities Co., Ltd., First Capital Securities Co., Ltd., and Huachuang Securities Co., Ltd. [2] - The complete list of new general lead underwriters includes: 1. Caitong Securities Co., Ltd. 2. First Capital Securities Co., Ltd. 3. Huachuang Securities Co., Ltd. 4. Huatai United Securities Co., Ltd. 5. Shanxi Securities Co., Ltd. 6. Western Securities Co., Ltd. 7. JPMorgan Chase Bank (China) Co., Ltd. 8. DBS Bank (China) Ltd. [2] Group 2: New Technology Innovation Lead Underwriter - Zhongyin International Securities Co., Ltd. has been added as the lead underwriter for technology innovation non-financial corporate debt financing tools, which includes supporting technology innovation bonds [2]. Group 3: New Underwriters - Fifteen new members have been added as underwriters for non-financial corporate debt financing tools, including Jiangsu Zhangjiagang Rural Commercial Bank Co., Ltd., Bohai Securities Co., Ltd., and Founder Securities Co., Ltd. [3] - The complete list of new underwriters includes: 1. Jiangsu Zhangjiagang Rural Commercial Bank Co., Ltd. 2. Luzhou Bank Co., Ltd. 3. Rizhao Bank Co., Ltd. 4. Weifang Bank Co., Ltd. 5. Bohai Securities Co., Ltd. 6. Debon Securities Co., Ltd. 7. Founder Securities Co., Ltd. 8. Guohai Securities Co., Ltd. 9. Guolian Minsheng Securities Co., Ltd. 10. Guoxin Securities Co., Ltd. 11. Huaxin Securities Co., Ltd. 12. Huayuan Securities Co., Ltd. 13. Shanghai Securities Co., Ltd. 14. Shiji Securities Co., Ltd. 15. Southwest Securities Co., Ltd. [3] Group 4: Regulatory Requirements - The qualifications for engaging in non-financial corporate debt financing tool underwriting are limited to legal entities participating in the market evaluation [4]. - Lead underwriters and underwriters are required to establish relevant departments, equip dedicated personnel, and develop operational procedures, risk management, and internal control systems for underwriting activities [4]. - Lead underwriters must collaborate with independent lead underwriters to conduct underwriting business and may independently engage in underwriting after gaining sufficient experience [4].

Core Viewpoint - Chongqing Sanfeng Environment Group Co., Ltd. plans to use idle self-owned funds of RMB 100 million to purchase fixed-income certificates issued by Southwest Securities, which constitutes a related party transaction but does not qualify as a major asset restructuring [1][3][12]. Group 1: Transaction Overview - The company intends to invest in fixed-income certificates to enhance the efficiency of idle funds while ensuring operational capital needs and overall financial safety [3][11]. - The transaction has been approved by the company's board of directors and does not require shareholder approval as it does not meet the threshold for significant transactions [3][12]. Group 2: Related Party Information - Southwest Securities, the issuer of the fixed-income certificates, is a related party, with the company holding 0.37% of its shares [4][5]. - As of September 30, 2025, Southwest Securities reported total assets of RMB 96.53 billion and net profit of RMB 705.74 million for the first three quarters of 2025 [6]. Group 3: Financial Product Details - The fixed-income certificates are expected to provide a stable return with a low risk profile, and the company has a history of successful transactions with Southwest Securities [8][10]. - The investment aims to avoid idle funds and promote the optimization of state-owned assets [11]. Group 4: Approval Process - The transaction was reviewed and approved by the company's independent directors and the audit committee before being presented to the board for final approval [12][19].

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 证券代码：600369 证券简称：西南证券 公告编号：临2025-055 西南证券股份有限公司 第十届董事会第二十二次会议 决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 西南证券股份有限公司（以下简称公司）第十届董事会第二十二次会议于2025年12月18日以电子邮件方 式发出会议通知和相关材料，于2025年12月23日、12月26日发出相关补充通知及材料，于2025年12月30 日在公司总部大楼以现场和视频方式召开。本次会议应出席董事9人，实际出席董事9人，姜栋林董事 长、杨雨松董事和李军董事现场出席本次会议，张敏董事、谭鹏董事、龚先念董事、黄琳独立董事、徐 秉晖独立董事和付宏恩独立董事视频出席本次会议。公司部分高级管理人员列席本次会议。本次会议由 姜栋林董事长主持，会议的召集、召开及表决程序符合《中华人民共和国公司法》《公司章程》等有关 规定。 本次会议以记名投票方式审议以下议案： 一、关于公司管理层人员2024年度考核结果的议案 分项表决 ...

Governance and Management Changes - Company has announced several governance measures including the establishment of a new Investment Banking Division and adjustments to the responsibilities of three departments within the Securities Investment Division [1] - The company has set the self-operated investment limit for 2026, with equity securities and derivatives investment not exceeding 80% of net capital, and non-equity investments not exceeding 400% of net capital, pending shareholder approval [1] - The company has appointed He Jiang as the new Chief Information Officer, who has extensive experience in financial technology and securities industry management [1] Audit and Compliance Enhancements - The company has strengthened its audit compliance by changing the signing auditor for the 2025 audit from Xiao Guichun to Tang Xueqin due to internal adjustments at the auditing firm Tianjian Accounting Firm [2] - Tang Xueqin has been involved in the company's audit work since 2022 and has signed the audit reports for 2022-2024, ensuring no adverse impact on the annual audit process [2]

近日，公司收到天健出具的《关于变更签字注册会计师的函》，现将相关变 更情况公告如下： 证券代码：600369 证券简称：西南证券 公告编号：临2025－057 西南证券股份有限公司 关于变更签字注册会计师的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 西南证券股份有限公司（以下简称公司）于 2025 年 8 月 14 日召开第十届董 事会第十八次会议，于 2025 年 9 月 26 日召开公司 2025 年第一次临时股东会审 议通过《关于选聘公司 2025 年财务报告及内部控制审计项目中介机构的议案》， 同意聘请天健会计师事务所（特殊普通合伙）（以下简称天健）为公司 2025 年财 务报告及内部控制审计项目中介机构，费用共计 88 万元（含异地差旅费）（详见 公司于 2025 年 8 月 15 日、2025 年 9 月 27 日在《中国证券报》《上海证券报》《证 券时报》及上海证券交易所网站（www.sse.com.cn）披露的《续聘会计师事务所 公告》《2025 年第一次临时股东会决议公告》）。 三、其他说明 ...

证券代码：600369 证券简称：西南证券 公告编号：临2025－056 西南证券股份有限公司 关于首席信息官变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 西南证券股份有限公司（以下简称公司）董事会于近日收到华明先生辞去公 司首席信息官的书面报告，具体如下： | 姓名 | 离任职务 | 离任时间 | 原定任期 | 离任 | 是否继续在上 | | 是否存在未 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 到期日 | 原因 | 市公司及其控 股子公司任职 | 具体职务 | 履行完毕的 公开承诺 | | 华明 | 首席信息官 | 2025.12.30 | 2026.12.24 | 工作 | 是 | 信息技术部 一级资深经 | | | | | | | 调整 | | | 否 | | | | | | | | 理 | | 根据《中华人民共和国公司法》《公司章程》等规定，华明先生的辞职报告 自送达公司董事会之日起生效。 公司董事会对华明先生在担任首席 ...